We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » CLINICAL TRIALS IN LOW-COST COUNTRIES COULD MEAN HUGE SAVINGS
CLINICAL TRIALS IN LOW-COST COUNTRIES COULD MEAN HUGE SAVINGS
August 6, 2004
In what is sure to get the attention of many drugmakers, GlaxoSmithKline’s (GSK’s) top executive said that moving human clinical trials to low-cost countries could save the company more than $200 million annually in R&D costs.